Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive,n         HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

首页> 外文期刊>Clinical Infectious Diseases >Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive,n HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

【24h】

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive,n HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

机译：接受抗病毒治疗的未接受过HIV-1感染的初次接受cART治疗的人在接受48周治疗后，联合抗逆转录病毒疗法（cART）是否会改变脑功能测试的变化？随机对照研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Neurocognitive impairment remains prevalent, despite combination antiretroviral therapy (cART). Differences between changes in cerebral function and alternative cARTs have not been prospectively assessed.

机译：背景。尽管联合使用抗逆转录病毒疗法（cART），神经认知功能障碍仍很普遍。尚未对脑功能变化和替代性cARTs之间的差异进行前瞻性评估。

著录项

来源
《Clinical Infectious Diseases》 |2010年第6期|p.920-929|共10页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. [J] . Winston A, Duncombe C, Li P Clinical infectious diseases . 2010,第6期

机译：对于未接受过HIV-1感染的初次接受cART治疗的患者，选择抗逆转录病毒疗法（cART）联合治疗48周后是否会改变脑功能测试的变化？一项随机对照研究。
2. Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. [J] . Markowitz M, Nguyen BY, Gotuzzo E, JAIDS: Journal of acquired immune deficiency syndromes . 2007,第2期

机译：在未经治疗的HIV-1感染患者中，HIV-1整合酶抑制剂raltegravir作为联合治疗的一部分，具有快速，持久的抗逆转录病毒作用：一项为期48周的对照研究的结果。
3. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. [J] . Flexner C, Tierney C, Gross R, Clinical infectious diseases . 2010,第7期

机译：初次治疗的患者每天一次与每天两次联合抗逆转录病毒疗法的比较：AIDS临床试验组（ACTG）A5073的结果，一项为期48周的随机对照试验。
4. Maraviroc as a Switch Option in HIV-1–infected Individuals With Stable Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized Multicenter MARCH Study [O] . Sarah Lilian Pett, Janaki Amin, Andrejz Horban, -1

机译：Maraviroc作为切换选择在其第一个核苷/核苷酸逆转录酶抑制剂+利托那韦增强蛋白酶抑制剂治疗方案上具有稳定良好控制的HIV复制和R5-嗜性病毒的HIV-1感染个体中：第48周随机结果多中心MARCH研究
5. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. [O] . Winston, A, Duncombe, C, Li, PC, 2009

机译：选择抗逆转录病毒联合治疗（caRT）是否会改变48周后脑功能检测的变化，这些患者在接受caRT治疗的初治HIV-1感染者中没有？一项随机对照研究。

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive,n HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

摘要

著录项

相似文献

相关主题

期刊订阅